Kirby Co. (NYSE: KEX), Galectin Therapeutics (OTC: GALT), Goodrich Petroleum Co. (NYSE: GDP), Gen-Probe Incorporated (NASDAQ: GPRO) and Groupon (NASDAQ: GRPN) getting new coverage from analysts.
Global Hunter Securities initiated coverage on Galectin Therapeutics (GALT). They placed a “Speculative Buy” rating and a price target of $3.00 on the company.
Global Hunter Securities initiated coverage on Goodrich Petroleum Co. (GDP). They placed a “Neutral” rating on the company.
Deutsche Bank (NYSE:DB) initiated coverage on Gen-Probe Incorporated (GPRO). They placed a “Buy” rating and a price target of $70.50 on the company.
Stifel Nicolaus initiated coverage on Groupon (GRPN). They placed a “Hold” rating on the company.
Evercore Partners initiated coverage on Kirby Co. (KEX). They placed an “Overweight” rating on the company.
Tuesday, December 20, 2011
Kirby (KEX) (GALT) (GDP) (GPRO) (GRPN) Get New Coverage
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment